Alliance for Multispecialty Research, LLC

Summary

Alliance for Multispecialty Research, LLC is a medical facility located in Knoxville, Tennessee. This center is recognized for care of Obesity, Type 2 Diabetes, Childhood Obesity, I Am A Healthy Volunteer, Coronavirus and other specialties. Alliance for Multispecialty Research, LLC is involved with conducting 71 clinical trials across 105 conditions. There are 6 research doctors associated with this hospital, such as William Smith, Lisa Connery, Michael A Rausch, and Harry E Studdard, MD.

Top PIs

Clinical Trials running at Alliance for Multispecialty Research, LLC

Obesity

Diabetes

Type 2 Diabetes

Healthy Subjects

Childhood Obesity

Cardiovascular Disease

Psoriasis

Vestibular Migraine

Migraine

Atherosclerosis

Tirzepatide

for Psoriasis and Obesity

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up to 12 months.

Recruiting

3 awards

Phase 4

Tirzepatide

for Type 1 Diabetes and Obesity

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 weeks.

Recruiting

1 award

Phase 3

1 criteria

Tirzepatide

for Adolescent Obesity

The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition and physical activity in adolescents with obesity and multiple weight related comorbidities. The study will last approximately 76 weeks and may include up to 23 visits. Participants who have completed the primary 72-week GPIX study and have been off treatment for no more than 12 weeks (including the 4-week safety follow-up period), will have the opportunity to receive an additional 156 weeks of treatment with tirzepatide as well as continuing the lifestyle intervention.

Recruiting

1 award

Phase 3

1 criteria